West Pharmaceutical Services, Inc’s recent filing unveils that its VP & Treasurer Witherspoon Charles unloaded Company’s shares for reported $0.22 million on Oct 29 ’24. In the deal valued at $310.40 per share,703 shares were sold. As a result of this transaction, Witherspoon Charles now holds 1,253 shares worth roughly $0.26 million.
Then, Witherspoon Charles sold 1,029 shares, generating $308,700 in total proceeds. Upon selling the shares at $300.00, the VP & Treasurer now owns 1,478 shares.
Before that, Hofmann Thomas W sold 617 shares. West Pharmaceutical Services, Inc shares valued at $225,773 were divested by the Director at a price of $365.92 per share. As a result of the transaction, Hofmann Thomas W now holds 43,565 shares, worth roughly $8.95 million.
Evercore ISI initiated its West Pharmaceutical Services, Inc [WST] rating to an Outperform in a research note published on March 18, 2025; the price target was $275. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who increased its forecast for the stock in mid February from “a Hold” to “a Buy”. Citigroup began covering WST with “Buy” recommendation on January 08, 2025. Wolfe Research started covering the stock on December 13, 2024. It rated WST as “a Peer perform”.
Price Performance Review of WST
On Tuesday, West Pharmaceutical Services, Inc [NYSE:WST] saw its stock fall -2.66% to $205.36. Over the last five days, the stock has lost -3.79%. West Pharmaceutical Services, Inc shares have fallen nearly -37.31% since the year began. Nevertheless, the stocks have fallen -44.27% over the past one year. While a 52-week high of $372.52 was reached on 01/28/25, a 52-week low of $187.43 was recorded on 04/09/25. SMA at 50 days reached $218.79, while 200 days put it at $286.66.
Levels Of Support And Resistance For WST Stock
The 24-hour chart illustrates a support level at 203.15, which if violated will result in even more drops to 200.94. On the upside, there is a resistance level at 209.21. A further resistance level may holdings at 213.06. The Relative Strength Index (RSI) on the 14-day chart is 40.97, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.80, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 59.02%. Stochastics %K at 53.80% indicates the stock is a holding.
